Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: The Role of CAR T-Cell Therapies and Bispecific Antibodies in Treating Hematologic Cancers

  • By

  • Yangmin Zhu

  • August 18, 2026

Share

Original Source(s)

Related Content